Tuberculosis, which is caused by Mycobacterium tuberculosis (M. tb), is one of the most important infectious diseases in the world. Although many functional studies have been conducted on M. tb proteins in the post-genomic era, little is known about the function of many proteins expressed specifically during latency. Previously, we reported that Rv2041c from M. tb H37Rv is highly expressed under conditions of low pH and hypoxia, which represent the in vitro mimicry of latent tuberculosis. In the present study, increased expression levels of Rv2041c under hypoxia and low pH in vitro culture was confirmed by RT-PCR. Interestingly, Rv2041c showed significantly increased expression among genes of the same operon and genes belonging to the same functional group. Finally, the immune responses elicited by the recombinant (r) Rv2041c protein were investigated using ex vivo and in vivo models of M. tb infection. A significantly high level of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-12p40 was detected in a dose-dependent manner by treatment of murine bone marrow-derived macrophages with rRv2041c protein. In addition, IFN-γ and TNF-α secretion increased after stimulation with purified Rv2041c protein to lymphocytes from latent and active TB mice in a modified Cornell model. In conclusion, our findings suggest that Rv2041c is a new T-cell antigen and could be a potential vaccine candidate against M. tb infection by inducing a strong cellular immune response.
INTRODUCTION
Tuberculosis (TB) causes more than 2 million deaths every year (1) . The ability of Mycobacterium tuberculosis (M. tb) to persist in the host for long periods of time causes long-term disease (2) . The chronic nature of the disease is likely due to the bacterium needing to adapt to a continually changing host environment, severely complicating any attempts to identify better therapeutics or diagnostics for this disease (3) .
Although drug-susceptible TB can be treated successfully with a 6-month regimen involving three of four drugs (WHO DOTS strategy, >95% cure rate), the combined challenges of timely diagnosis, socioeconomic factors in TB endemic areas, and the fact that bacterial clearance requires many months of treatment have prevented the successful global control of TB (4) . The only current Bacillus Calmette-Guérin (BCG) vaccine, the most widely used in the world, is not completely protective. BCG is ineffective in individuals pre-sensitized by exposure to environmental mycobacteria prior to vaccination or M. tb infection (5, 6 ).
In addition, BCG is a live vaccine and the development of protective immunity after vaccination appears to require BCG replication in the host, which can be prevented by a pre-existing immune response that can cross-react with BCG (7) . Therefore, a novel and efficacious vaccine to replace BCG is needed urgently to control and eliminate TB.
Progress in mycobacterial proteomics, functional genomics, and recombinant biotechnology to produce and purify mycobacterial proteins might lead to the development of vaccines from putative candidates (8) Several studies have reported on the genes and proteins that are highly expressed in macrophages and in the in vitro dormancy state to discover vaccine candidates (9~11).
However, the contribution of these proteins to host immune responses must be evaluated following ex vivo and in vivo M. tb infection models.
In a previous study, the Rv2041c of M. tb H37Rv was found (by differential expression using a customized amplification library [DECAL] ) to be specifically induced under acidic and hypoxic conditions similar to those in a phagocytosed environment (12) , and may be important for survival in the host. Currently, the host immune response to Rv2041c of M. tb H37Rv is not completely elucidated.
Rv2041c is thought to be a sugar-binding lipoprotein component of the ATP-binding cassette (ABC) sugar transport system. In total, 38 ABC transporter proteins have been identified in M. tb, only four of which are assigned for a role in carbohydrate import (13 (14) . Experimental data concerning mycobacterial lipoprotein function are rare. 
MATERIALS AND METHODS

Plasmid and vector construction
The cloning vector plasmid pGEM 
Extraction of RNA from M. tuberculosis H37Rv
Total RNA from M. tb H37Rv was isolated using a catrimox-14 RNA isolation kit (Takara, Shiga, Japan) according to the manufacturer's instructions, with a protocol as described previously (17) . Bacterial cells were pelleted, 
Semi-quantitative RT-PCR
The first-strand cDNA was obtained from 1 μg total RNA with reverse transcriptase and random primer at 42℃ for 60 min. Reactions were stopped by heat inactivation for 5 min at 95℃ and chilled on ice. Initially RT-PCR was carried out using primers for amplifying rpoB to optimize the cDNA concentration. The PCR was carried out using 1 μl of single-stranded cDNA for 30 cycles of 1 min denaturing at 95℃, 1 min annealing at 51℃, and 1 min extension at 72℃. Sequences of the specific oligonucleotide primers used for PCR amplification and the size of the predicted PCR products are shown in Table 1 . The PCR products were analyzed with 1% agarose gel electrophoresis and the intensity of each band was calculated using Quantity One software (Version 4.1.0; Bio-Rad, Hercules, CA, USA). All samples were compared to normal culture (oxygen pressure of 21%, pH 7.2; condition 1) and the gene expression level of this condition corresponds to 1. The results were expressed as the fold induction relative to the control value of normal condition.
Cytokine production in murine BMDMs by stimulation with Rv2041c protein
To determine the responses in macrophages by the stimulation with rRv2041c, murine bone marrow-derived macrophages (BMDMs) were used for ex vivo macrophage M. tuberculosis infection. Specific pathogen-free female C57BL/6 mice (Japan SLC, Shijuoka, Japan) at 5~6 weeks of age were used for the isolation of BMDMs. BMDMs were differentiated for 6 days in M-CSF-containing media, as described previously (18, 19) . The culture medium consisted of DMEM that was supplemented with 20% L929 cell-conditioned medium (as a source of M-CSF), 10% heat-inactivated FBS, 1 mM sodium pyruvate, 50 U/ ml penicillin, 50 μg/ml streptomycin, and 5 × 10 
Determination of cytokine concentration by ELISA
Cytokine production (IFN-γ, TNF-α, IL-6 and IL-12p40)
was measured with commercial mouse enzyme-linked immunosorbent assay (ELISA) kits (BD Pharmingen, San Diego, CA, USA) following the procedure provided by the manufacturer. Cytokine concentrations in the samples were calculated using standard curves generated from recombinant cytokines, and the results were expressed in picograms per milliliter.
RESULTS
Purification of the rRv2041c protein
The rRv2041c protein containing a C-terminal histidine tag was purified using Ni-NTA resin. The purified protein displayed the expected molecular mass by SDS-PAGE analysis (Kim et al., submitted). The purified protein was dialyzed against PBS to remove the salts, followed by SDS-PAGE analysis to confirm that the dialyzed protein remained intact (Fig. 2) . The small sized peptide bands are tb (Fig. 3) . When altered by oxygen tension or pH, the transcripts of Rv2041c increased; however, the transcripts of other sugar-binding protein genes showed no significant change.
Cytokine production in murine BMDMs in response to Rv2041c protein
Because macrophages play pivotal roles in mycobacterial infections by secreting pro-inflammatory cytokines to activate a variety of immune effector cells, cytokine production by stimulation with rRv2041c in macrophages was exploited.
The production of proinflammatory cytokines such as TNF-α, IL-6, and IL-12 during M. tb infection is essential for the activation of effector cells for innate resistance (22~ 24). When BMDMs from mice were treated with varying concentrations (0.5, 1, 5 μg/ml) of purified rRv2041c for 18 h, the secretion of TNF-α, IL-6, and IL-12p40 in the culture medium increased significantly compared to those treated with 1 μg/ml LPS as a positive control (Fig. 4 ).
Significant differences (p < 0.05; p < 0.01) compared to Fig. 5 ; p < 0.01). As shown in Fig. 5A and B, the spleen cells in active TB produced much higher levels of IFN-γ than did the splenocytes in latent TB.
And, TNF-α production at day 1 was also significantly induced by rRv2041c protein in latent and active TB mice production (27, 28) . IL-6 has been associated with protection against M. tb with a role in granuloma maintenance. It is clear that the maintenance of granulomas requires antigenspecific T cells (22) . IL-6 acts as a regulator of the T cell responses that are critical for the maintenance of granulomas, especially during infection. IL-6 was higher in TB patients than in healthy controls (29) . In addition, IL-12 has been shown to be crucial in the development of protective immunity against TB, and in the maintenance of latency.
Persistent IL-12 production is necessary for the maintenance of Th1-dependent host resistance to M. tb (24) . This is important in vaccine design. 
